A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
< b > Condition < /b > : Avian Influenza < br/ > < b > Interventions < /b > : Biological: aH5N1c; Biological: Placebo < br/ > < b > Sponsors < /b > : Seqirus; Biomedical Advanced Research and Development Authority < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
Condition: Avian InfluenzaInterventions: Biological: aH5N1c; Biological: PlaceboSponsors: Seqirus; Biomedical Advanced Research and Development AuthorityRecruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
< b > Condition < /b > : Avian Influenza < br/ > < b > Interventions < /b > : Biological: aH5N1c; Biological: Placebo < br/ > < b > Sponsors < /b > : Seqirus; Biomedical Advanced Research and Development Authority < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
Condition: Avian Influenza Interventions: Biological: aH5N1c; Biological: Placebo Sponsors: Seqirus; Biomedical Advanced Research and Development Authority Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
Condition: Avian InfluenzaInterventions: Biological: aH5N1c; Biological: PlaceboSponsors: Seqirus; Biomedical Advanced Research and Development AuthorityRecruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
< b > Condition < /b > : Avian Influenza < br/ > < b > Interventions < /b > : Biological: aH5N1c; Biological: Placebo < br/ > < b > Sponsors < /b > : Seqirus; Biomedical Advanced Research and Development Authority < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials